Przedsiębiorstwo Farmaceutyczne Farmapolsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-12-05
Share capital
2 000 000,00 PLN
Activity description

Przedsiębiorstwo Farmaceutyczne Farmapol is a company that manufactures medications, dietary supplements, and cosmetics. They offer a range of products aimed at health and beauty, including over-the-counter and prescription medications, as well as specific formulations like ASMAG® and ZINCAS®. Their focus includes skin care, muscle health, and immune support.

Registered address
ul. Święty Wojciech 29, 61-749 Poznań, Poland
Website
farmapol.plWebsite active
Email
Email warning
Phone
Social media
Electronic delivery address
AE:PL-39743-21160-SBWBJ-20

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 21.46mMedianUSD 816.16kAverageUSD 29.28m
Net profit
This companyUSD 7.36mMedianUSD 8.96kAverageUSD 2.64m
Operating costs
This companyUSD 12.32mMedianUSD 701.47kAverageUSD 19.26m
Assets
This companyUSD 24.37mMedianUSD 800.13kAverageUSD 29.34m

Industry

Bank accounts

Registered as a VAT taxpayer on 2003-12-31. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

21 public aid cases recorded, with a total value of $462,795.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$26,118
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1,683
De minimis aid (in accordance with Commission Regulation 2023/2831)
$884

European Funds

ProjectEU co-financing
Prace badawczo-rozwojowe nad nowym lekiem Asmag B6 FORTE
$108.9K

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Wojciech Kęsy — President of the Management Board
Małgorzata Mroczkowska — Vice President of the Management Board

Manner of representation

For the submission of declarations of will and entering into liabilities on behalf of the company, as well as for performing other legal acts transferring rights with a value exceeding PLN 100,000, the joint declaration of two members of the management board is required. Each member of the management board may independently submit declarations or undertake liabilities up to PLN 100,000. If the management board is multi-member, the joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required for the submission of declarations on behalf of the company concerning non-property matters (including the submission of registration applications), in accordance with Article 205 § 1 of the Commercial Companies Code.

Supervisory board

Beata Chlebowska — Supervisory Board Member
Danuta Preuss — Supervisory Board Member
Kinga Rybka Knast — Supervisory Board Member

Ownership

OwnerSharesShare valueStake
Kinga Rybka Knast (59)
5,409$73,055.1113.5225%
Barbara Szematowicz (73)
8,080$109,130.2020.2%
Others
26,511$358,063.2166.2775%

Beneficial owners

Person
Barbara Szematowicz (73)

Competitors

Name
PolfarmexS.A.
Wrocławskie Zakłady Zielarskie HerbapolS.A.
Phytopharm KlękaS.A.
Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A.
Poznańskie Zakłady Zielarskie HerbapolS.A.
VipharmS.A.
Fagronsp. z o.o.
Przedsiębiorstwo Produkcyjno-Handlowe EwaS.A.
MedicofarmaS.A.
Krakowskie Zakłady Zielarskie Herbapol w KrakowieS.A.

Change history

DateEvent
2022-05-13Address change
2022-05-13Name change
2021-09-22Name change
2021-06-29Name change
2002-06-18Share capital change

FAQ

Last updated: 2026-06-12